Whitepapers

Oct 05, 2017
Sponsored Content
This white paper examines how a top brand integrated a data-driven patient outreach campaign using multiple communication mediums and its subsequent impact on patient adherence.
Oct 01, 2017
Sponsored Content
This is a bit over on words – lmk if it works / Whitepaper abstract: “Explore how Life Sciences organizations can accelerate Real World Evidence (RWE) to achieve faster time to insight, in a comprehensive and cost efficient manner. Download this white paper to learn about challenges, solutions and most importantly — how to equip your organization for success.”
Oct 01, 2017
Sponsored Content
For Life Sciences companies, real world evidence initiatives present a golden opportunity to demonstrate the clinical and economic value of their drugs and medical devices—and to get those products to market faster. However, the success of real world evidence development efforts depends heavily upon your organization’s capacity to generate results in a comprehensive and cost-efficient manner. The ability to extract more value from healthcare data is key to leveraging real world evidence to greater competitive advantage. Is your organization equipped for success?
Oct 01, 2017
Sponsored Content
A top 10 pharmaceutical company wanted to focus on enhancing field intelligence to get a better picture of the local landscape and key players. With advanced data and analytics they were able to see relationships between providers that weren’t evident before, allowing them to target teams versus individuals.
Sep 14, 2017
Sponsored Content
By ERT
Patient generated, or humanistic, Real-World Data (RWD) is playing an increasingly important role in informing key healthcare decisions. This summary will highlight the reasons behind this trend, and share best practices for how a digital strategy can overcome typical challenges of patient data capture, enabling sponsors to effectively integrate the patient voice into their RWE programs.
Sep 12, 2017
Sponsored Content
Patient centricity done right yields greater trial enrollment with lower costs. There are 3 guiding factors to the PEPtrials’ engagement with patients: learn, target, cultivate—with effort and empathy.
Sep 01, 2017
Sponsored Content
By recognizing key trends and patterns that allow patients to be diagnosed earlier and therapy to be initiated sooner, AI techniques are already delivering results for three stakeholder groups — life sciences companies, health insurers and diagnostic labs. For each group, the AI-derived insight has direct clinical, business and financial implications.
Aug 04, 2017
Sponsored Content
OpenText recently acquired Dell Technology’s Enterprise Content Division, including Documentum. Biopharmaceutical firms have been wondering how the acquisition will affect their businesses. Pharmaceutical Executive recently spoke with Adam Howatson, chief marketing officer for OpenText, about what users can expect in terms of ongoing investment and innovation in hybrid internal and cloud-based ECM solutions.
Jul 22, 2017
Sponsored Content
This summary will introduce the concept of managing the lifecycle of regulated promotional material with OpenText Marketing Content Management (MCM) for Life Sciences, a platform designed to help teams execute their assets through development and delivery more strategically, while maintaining regulatory compliance and quality control.
Jun 20, 2017
Sponsored Content
A listing of the top 50 largest acute care hospitals in the US; ranked by size and specialty rank.
native1_300x100
lorem ipsum